Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Preprint
Data sources: ZENODO
Zenodo
Claim

Repurposed Tadalafil-Rapamycin Combination for Penile Tissue Engineering

descriptionPublicationkeyboard_double_arrow_right Preprint Under curationPublisher:Zenodo
Authors: MedicOath Autonomous Discovery Engine;

doi: 10.5281/zenodo.19833084

Repurposed Tadalafil-Rapamycin Combination for Penile Tissue Engineering

Abstract

Tadalafil (PDE5 inhibitor) increases cGMP levels enhancing VEGFA expression, while low-dose rapamycin inhibits mTORC1 promoting autophagy-mediated stem cell maintenance. Combined therapy enhances angiogenesis via PECAM1+ endothelial cell proliferation and maintains stemness of tissue-engineered penile constructs.

Powered by OpenAIRE graph
Found an issue? Give us feedback